Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.
about
Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatmentsiRNAs: potential therapeutic agents against hepatitis C virusNonviral gene transfer to skeletal, smooth, and cardiac muscle in living animalsEnhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.Inhibitory RNA molecules in immunotherapy for cancer.Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injuryConstruction and identification of Fas-targeting siRNA-expressing plasmidTowards understanding the epigenetics of transcription by chromatin structure and the nuclear matrix.Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination.Gene therapy for the inner ear: challenges and promises.Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions.Alternative for anti-TNF antibodies for arthritis treatment.The genetic and molecular bases of monogenic disorders affecting proteolytic systems.Interfering with cancer: a brief outline of advances in RNA interference in oncology.Gene therapy progress and prospects: recent progress in transgene and RNAi expression cassettes.Cell-specific targeting of lipid-based carriers for ODN and DNA.Prospects of RNA interference therapy for cancer.Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials.RNA interference in embryonic stem cells and the prospects for future therapies.Immunological research using RNA interference technology.RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency.Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.Strategies for short hairpin RNA delivery in cancer gene therapy.Pro-chondrogenic effect of miR-221 and slug depletion in human MSCs.Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf.Frog Prince transposon-based RNAi vectors mediate efficient gene knockdown in human cells.RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma.A human full-skin culture system for interventional studies.RNAi quashes polyQ.Protective effects of IL28RA siRNA on cardiomyocytes in hypoxia/reoxygenation injury.Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction.Preliminary study of microRNA-126 as a novel therapeutic target for primary hypertension.In vitro and in vivo suppression of GJB2 expression by RNA interference.Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents.
P2860
Q27015027-A38CFF43-C269-44F7-B371-51615DF34691Q27694682-18C08A27-937D-4A9D-8FE6-8467A82AF062Q30431522-8401C57D-F5F2-4137-98A6-31F942EFC277Q33336392-0C54A755-2BBD-489E-BFF7-EA7AFAC2D6CEQ34033910-EE74B2EA-8BDF-465C-8044-9E7C97E381EFQ34039481-723B8E0D-4637-4212-8179-AAA0AF877984Q34425383-FC59728D-2BB9-476F-AAB3-A62D2BF80CAFQ34493334-87943153-02A0-46FE-86A6-61EB9E13F180Q35066303-F47EFCF3-3FF0-4AA9-B983-08609C57759DQ35095260-8B01DA74-C6F9-451E-9C22-D5EB84F51FFCQ35103677-EBE52CBD-C333-4BCF-80D5-B65ACD35BA89Q35285800-E9D9B4C2-5C37-4DFB-BAB9-C3D42B8CAEF9Q35448691-2373BDA5-71F8-45FD-AD09-C375139D6AE1Q35997754-D4D794E5-681A-44DB-8154-509CC9B954ECQ36091296-7DC3587F-40CA-4322-AC43-87A3AC62FFBEQ36272601-3E127997-92B3-4FAD-B33F-2DA4C2CBBE1FQ36337922-64BE8377-8F7C-452C-858E-645C9B968A1EQ36401746-1B40CF4F-1D10-4DF4-931D-2C05F39E401DQ36415321-3D5A15BB-F0F1-480A-A3ED-9EC2A00D61EAQ36788606-1A5CDA99-CD51-4CFA-87A8-4BFE16D26A82Q36983827-7545FDD7-8F71-4AD0-85D9-4D3ADA861731Q37331649-3E6DD754-9B45-490D-A22A-14437E0CAF15Q37598928-A091590D-C697-4C57-929B-50FC219FD43DQ38219817-E5776E74-C7CF-4C00-ADF3-B348B6029FA8Q40223081-96F9E060-B435-4E3B-ADBF-940736E44893Q42141814-D706E6EC-B5F6-4120-B9EB-3FEB1831B881Q42714252-5CFECDF7-7DA4-4B08-AEA9-6BD46D46A59FQ43197715-6527012D-428A-4A78-86F4-5F6FE83AF1DAQ45001881-89940BD8-136E-4B76-B06E-A0FE1FA7F852Q45730304-E99178A9-9551-4EAF-818B-F07D3924CA45Q45870866-FC902396-8288-4A49-9C24-F33339D3361DQ47546902-9D2C2B5C-0E80-4C2F-8C63-8CC3EDC34009Q50473508-6BCF05BA-54CA-4A2E-B2EB-C43FD9CB60EAQ51001472-F8B0B5E8-B51D-41BD-9B3B-BA4E8C4BE360
P2860
Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gene therapy progress and pros ...... he impact of RNA interference.
@ast
Gene therapy progress and pros ...... he impact of RNA interference.
@en
type
label
Gene therapy progress and pros ...... he impact of RNA interference.
@ast
Gene therapy progress and pros ...... he impact of RNA interference.
@en
prefLabel
Gene therapy progress and pros ...... he impact of RNA interference.
@ast
Gene therapy progress and pros ...... he impact of RNA interference.
@en
P2860
P356
P1433
P1476
Gene therapy progress and pros ...... the impact of RNA interference
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302324
P577
2004-08-01T00:00:00Z